Literature DB >> 3685340

Angiographic ablation of parathyroid adenomas: lessons from a 10-year experience.

D L Miller1, J L Doppman, R Chang, J T Simmons, T J O'Leary, J A Norton, A M Spiegel, S J Marx, G D Aurbach.   

Abstract

Angiographic ablation of parathyroid adenomas with ionic contrast material was performed in 24 patients with persistent hyperparathyroidism who had undergone at least one prior unsuccessful surgical resection; 23 had mediastinal adenomas. The success rate was 83% at 1 month after ablation and 71% at both 5 and 9 years. Ablation was successful in 85% of the patients in whom the catheter could be wedged into the artery feeding the adenoma. Long-term success was achieved in 89% of the patients in whom contrast enhancement persisted in the adenoma on computed tomographic scans obtained 24 hours later. Acute complications were seen only in patients with glands supplied by the inferior or superior thyroid arteries. Long-term complications were limited to permanent hypocalcemia, present in 8% of patients. Even if unsuccessful for ablation, the procedure may provide localization and does not preclude surgical resection. It is recommended for most patients with persistent hyperparathyroidism and mediastinal adenomas, especially adenomas supplied by the internal thoracic artery.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3685340     DOI: 10.1148/radiology.165.3.3685340

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Feasibility of using hyperosmolar mannitol as a liquid tumor embolization agent.

Authors:  Lei Feng; Beverly A Kienitz; Carolyn Matsumoto; Jeffrey Bruce; Michael Sisti; Hoang Duong; John Pile-Spellman
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

2.  Results of a multidisciplinary strategy for management of mediastinal parathyroid adenoma as a cause of persistent primary hyperparathyroidism.

Authors:  G M Doherty; J L Doppman; D L Miller; M S Gee; S J Marx; A M Spiegel; G D Aurbach; H I Pass; M F Brennan; J A Norton
Journal:  Ann Surg       Date:  1992-02       Impact factor: 12.969

3.  Spontaneous regression of hypercalcemia in a patient with primary hyperparathyroidism and prolactinoma.

Authors:  V Baskar; D Kamalakannan; B M Singh; J Odum
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

Review 4.  Pre-operative localization and interventional treatment of parathyroid tumors: when and how?

Authors:  D L Miller
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 5.  Primary hyperparathyroidism.

Authors:  R Udelsman
Journal:  Curr Treat Options Oncol       Date:  2001-08

Review 6.  Challenges and pitfalls in the management of parathyroid carcinoma: 17-year follow-up of a case and review of the literature.

Authors:  Janneke E Witteveen; Harm R Haak; Job Kievit; Hans Morreau; Johannes A Romijn; Neveen A T Hamdy
Journal:  Horm Cancer       Date:  2010-11-19       Impact factor: 3.869

7.  Percutaneous Ultrasound-Guided Laser Ablation with Contrast-Enhanced Ultrasonography for Hyperfunctioning Parathyroid Adenoma: A Preliminary Case Series.

Authors:  Tianan Jiang; Fen Chen; Xiang Zhou; Ying Hu; Qiyu Zhao
Journal:  Int J Endocrinol       Date:  2015-12-16       Impact factor: 3.257

8.  Percutaneous Transsternal Cryoablation of Ectopic Parathyroid Adenoma in the Anterior Mediastinum.

Authors:  James Meek; Savannah Fletcher; Marcus Kessler; Aparna Komarraju; Cordell Privat; Mary Meek
Journal:  J Endocr Soc       Date:  2017-09-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.